Abstract
Background aims: Expansion of anti-CD25 bead-isolated human Tregs culture has paradoxically resulted in reduced suppressive activity, but the mechanism(s) responsible for these observations are poorly defined. Methods: Magnetic-bead isolated human CD25+ cells were expanded with anti-CD3/CD28 beads and high doses of rhIL-2. Detection of Fas and Fas ligand (Fas-L) expression, activation of Caspase 8, cell proliferation and cytokine production was evaluated by multi-color fluorescence-activated cell sorting analysis. The role of Fas-Fas-L-mediated cell death was dissected through the use of agonist or antagonist monoclonal antibodies directed at Fas and Fas-L. Results: Repeated expansion of bead-enriched CD4+CD25+ cells generated a cellular product with markedly reduced suppressive activity and with significantly increased CD8+ T cells and CD4+ T cells producing interferon-γ and/or interleukin-2. We showed that Fas-Fas-L-mediated apoptosis of CD4+FOXP3high cells and rapid cell-cycling of CD8+ Tcells were collectively responsible for the reduced proportion of CD4+FOXP3high cells in expanded cultures. The depletion of CD4+FOXP3high cells and activation of Caspase 8 in CD4+FOXP3high cells was attenuated by Fas antagonist antibody, ZB4, in short-term culture. However, the loss of CD4+FOXP3high cells during expansion was not prevented by either Fas or Fas-L antagonist antibodies. Conclusions: Taken together, the data show that Fas-Fas-L-mediated apoptosis may limit the expansion of anti-CD25 bead-isolated cells invitro.
Original language | English |
---|---|
Pages (from-to) | 1286-1296 |
Number of pages | 11 |
Journal | Cytotherapy |
Volume | 15 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2013 |
Externally published | Yes |
Bibliographical note
Funding Information:WZ was funded by NHSBT and Department of Haematology Trust Fund. The research benefited from funding by the United Kingdom National Health Service R&D Directorate through the National Institute of Health Research (NIHR) ( RP-PG-0310-1003 ) and the National Institute for Health Biomedical Research Centre Program . RD is supported by the Wellcome Trust Academic Clinical Fellowship Scheme.
Keywords
- Apoptosis
- Cell therapy
- Expansion
- FOXP3
- Fas
- Treg